Natural course of remission in IDDM during 1st yr after diagnosis.
about
Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial)Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1).Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet dataDiagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus.Characteristics and determinants of partial remission in children with type 1 diabetes using the insulin-dose-adjusted A1C definitionHelping high-risk youth move through high-risk periods: personally controlled health records for improving social and health care transitions.Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell functionThe metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.Spontaneous complete remission of type 1 diabetes mellitus in an adult - review and case report.Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the futurePreservation of beta-cell function in autoantibody-positive youth with diabetes.Teplizumab therapy for type 1 diabetes.Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.[C-peptide residual secretion makes difference on type 1 diabetes management?].Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes.A mathematical model for pattern of change in beta-cell reserve and factors affecting residual reserve within the first 2 years of type 1 diabetes.Factors Influencing Frequency and Duration of Remission in Children and Adolescents Newly Diagnosed with Type 1 Diabetes
P2860
Q28731029-C72E8418-3227-4419-AD67-FE561B7D90FBQ30505367-41DC6E65-FB76-4F10-8FBF-786FF51F0782Q30521476-227D423A-CDDA-4234-8FF0-2638B8DF9F15Q33628681-BDF760F9-ABDB-44C0-81AD-9CF8FFDAFBD3Q34181376-832B06F2-BD32-4771-8A13-87B2B275E1FEQ34607494-635A0908-3B1E-4D30-9E72-B59C589AECDFQ35797043-DCA89BD3-4240-4104-8C5A-69C893AFB3CCQ35976782-774DF031-2A62-4EAD-ADD0-E7B6A6F13CB3Q36181700-B98F3471-CDA0-453A-8542-098863FAFD0CQ37364899-81C01BCD-2CDB-4074-A292-5F437A2640B0Q37364982-E033ED7C-6ABF-4C79-AEF4-ACBAD4E0E60CQ37679927-C6740971-067A-4C7F-BD85-6DAFAFC0AEB0Q39375164-8A29CC50-D2E4-4720-A92B-FA2E2691FD93Q42503576-EBB247EB-DDC6-44D9-9138-1AB51BE0BF1EQ46625419-77ED6320-4BB5-4E5D-A1A8-0C6669982365Q51364276-D9899FF1-49C2-41DC-A168-FC30346C6DE9Q51538693-B3F04560-581F-41C0-8CF4-B7202A6C82D3Q58697903-BAED296D-1D63-432E-A899-5CC5EC5ACD9D
P2860
Natural course of remission in IDDM during 1st yr after diagnosis.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Natural course of remission in IDDM during 1st yr after diagnosis.
@en
Natural course of remission in IDDM during 1st yr after diagnosis.
@nl
type
label
Natural course of remission in IDDM during 1st yr after diagnosis.
@en
Natural course of remission in IDDM during 1st yr after diagnosis.
@nl
prefLabel
Natural course of remission in IDDM during 1st yr after diagnosis.
@en
Natural course of remission in IDDM during 1st yr after diagnosis.
@nl
P2093
P356
P1433
P1476
Natural course of remission in IDDM during 1st yr after diagnosis.
@en
P2093
Greulich B
Mandrup-Poulsen T
Pawlowski B
Ziegler AG
P356
10.2337/DIACARE.15.1.66
P407
P577
1992-01-01T00:00:00Z